Britt Roosenboom
Arnhem, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Mucosal kinase activity and inflammatory profiles in inflammatory bowel disease, and in relation to tofacitinib response.
Journal: Journal of Crohn's & colitis
Published: September 23, 2025
Fecal Calprotectin Levels in Post-Metabolic Bariatric Surgery Patients: A Retrospective Study.
Journal: Inflammatory intestinal diseases
Published: June 12, 2025
Compartment-driven imprinting of intestinal CD4 T cells in inflammatory bowel disease and homeostasis.
Journal: Clinical and experimental immunology
Published: March 19, 2023
Mucosal α4β7+ Lymphocytes and MAdCAM+ Venules Predict Response to Vedolizumab in Ulcerative Colitis.
Mucosal α4β7+ Lymphocytes and MAdCAM+ Venules Predict Response to Vedolizumab in Ulcerative Colitis.
Journal: Inflammatory bowel diseases
Published: October 12, 2022
Therapeutic drug monitoring of thiopurines: Effect of reduced 6-thioguanine nucleotide target levels in inflammatory bowel disease patients.
Journal: British journal of clinical pharmacology
Published: December 03, 2021
Mobile application to monitor inflammatory bowel disease patients on intravenous biologic treatment: a feasibility study.
Journal: Scandinavian journal of gastroenterology
Published: August 27, 2021
Distribution of mucosal PD-1 expressing T cells in patients with colitis of different etiologies.
Journal: Scandinavian journal of gastroenterology
Published: March 29, 2021
Homeostatic Function and Inflammatory Activation of Ileal CD8+ Tissue-Resident T Cells Is Dependent on Mucosal Location.
Journal: Cellular and molecular gastroenterology and hepatology
Published: November 05, 2020
Development of Mucosal PNAd+ and MAdCAM-1+ Venules during Disease Course in Ulcerative Colitis.
Journal: Cells
Published: March 07, 2020
Analysis of Intestinal T-Cell Subsets in Inflammatory Bowel Disease.
Journal: Inflammatory bowel diseases
Published: January 07, 2020
Improvement of Fatigue and Quality of Life in Patients with Quiescent Inflammatory Bowel Disease Following a Personalized Exercise Program.
Journal: Digestive diseases and sciences
Published: December 02, 2019
AlphaE Expression in Inflammatory Bowel Disease: a Biomarker for the use of Etrolizumab?
Journal: Journal of Crohn's & colitis
Published: November 13, 2018
Last Updated: 09/26/2026